Pacira BioSciences Inc (NAS:PCRX)
$ 17.24 -0.46 (-2.6%) Market Cap: 796.03 Mil Enterprise Value: 986.64 Mil PE Ratio: 0 PB Ratio: 1.06 GF Score: 71/100

Pacira Biosciences Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 12:30PM GMT
Release Date Price: $73.49 (+0.63%)
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst

Good morning, everybody. I'm Chris Schott at JPMorgan, and very pleased to be introducing Pacira today to kick off day 3 of the JPMorgan Healthcare Conference. From the company, we have Dave Stack, the company's Chairman and CEO; as well as Charlie Reinhart, the company's CFO. As a reminder, we're going to have a -- Dave is going to make a presentation. From there, we're going to turn it over to a Q&A session. (Operator Instructions)

So with that, let me turn the presentation over to Dave, and we'll go to the Q&A after that.

David M. Stack
Pacira BioSciences, Inc. - Chairman & CEO

Thank you, Chris, and good morning, everyone, and the typical disclosures as well as our thank you to JPMorgan for making it possible for us to spend a few minutes with you this morning. We are in an exciting time at Pacira. We continue to grow the company around our 3 growth pillars. What I'd like to highlight to start out the program is that our mission is consistent, to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot